WRF gives ISB a Phase 2 gift to advance clinical validations of SYGNAL technology By sygnomics_adm|2023-01-17T20:21:26+00:00June 20th, 2020|News|0 Comments Read More
WRF gives ISB a Phase 1 gift to explore commercialization potential for SYGNAL By sygnomics_adm|2023-01-17T20:20:27+00:00January 17th, 2019|News|0 Comments Read More
